Aims Diabetes mellitus (DM) is one of the most important cardiovascular risk factors. The aim of this study was to evaluate clinical correlates of DM, including management and outcomes, in the EURObservational Research Programme (EORP)-Atrial Fibrillation (AF) General Pilot (EORP-AF) Registry of the European Society of Cardiology. Methods and results We studied consecutive patients (N= 3101) enrolled in 70 centres of nine European countries between February 2012 and March 2013, and compared diabetics with non-diabetics during a 1-year follow-up. In the overall cohort, the prevalence of DM was 20.6%. Diabetics were older (71 ± 9 vs. 68 ± 12 years, P < 0.0001) and had more comorbidities, higher CHA2DS2-VASc score (4.6 ± 1.6 vs. 2.9 ± 1.7, P < 0.0001) and higher prevalence of permanent AF (21.5 vs. 16.0%, P = 0.0022). Quality of life amongst DM patients was significantly worse [atrial fibrillation quality of life questionnaire (AF-QoL) score 45.2 ± 19.2 vs. 49.3 ± 20.1, P < 0.0001]. Amongst diabetics, the use of electrical cardioversion (16.2 vs. 24.6%, P < 0.0001) and catheter ablation (3.3 vs. 8.6%, P < 0.0001) was lower, whilst oral anticoagulants were more often prescribed (84.3 vs. 78.9%, P = 0.0027). After one year, diabetic patients had significantly higher all-cause (11.9 vs. 4.9%, P < 0.0001), cardiovascular (6.2 vs. 1.9%, P < 0.0001), and non-cardiovascular mortality (2.3 vs. 1.1%, P = 0.0356). Conclusion In AF patients, DM is associated with a higher prevalence of comorbidities and a worse quality of life. After one year, all-cause, cardiovascular, and non-cardiovascular mortality were significantly higher in diabetic subjects.
|Data di pubblicazione:||2018|
|Titolo:||Management and prognosis of atrial fibrillation in diabetic patients: An EORP-AF General Pilot Registry report|
|Autore/i:||Fumagalli, Stefano; Said, Salah A.; Laroche, Cecile; Gabbai, Debbie; Boni, Serena; Marchionni, Niccolò; Boriani, Giuseppe; Maggioni, Aldo P.; Musialik-Lydka, Agata; Sokal, Adam; Petersen, Jens; Crijns, Harry J. G. M; Lip, Gregory Y. H.|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1093/ehjcvp/pvx037|
|Codice identificativo ISI:||WOS:000439821400012|
|Codice identificativo Scopus:||2-s2.0-85052973019|
|Codice identificativo Pubmed:||29309557|
|Citazione:||Management and prognosis of atrial fibrillation in diabetic patients: An EORP-AF General Pilot Registry report / Fumagalli, Stefano; Said, Salah A.; Laroche, Cecile; Gabbai, Debbie; Boni, Serena; Marchionni, Niccolò; Boriani, Giuseppe; Maggioni, Aldo P.; Musialik-Lydka, Agata; Sokal, Adam; Petersen, Jens; Crijns, Harry J. G. M; Lip, Gregory Y. H.. - In: EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY. - ISSN 2055-6837. - 4:3(2018), pp. 172-179.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris